Virulence and cellular interactions of Burkholderia multivorans in chronic granulomatous disease

Infection and Immunity

Volumn 77, Issue 10, 2009, Pages 4337-4344

  Zelazny, Adrian M ^a,b   Ding, Li ^a   Elloumi, Houda Z ^a,f   Brinster, Lauren R ^a   Benedetti, Fran ^a   Czapiga, Meggan ^a,g   Ulrich, Ricky L ^c,h   Ballentine, Samuel J ^a   Goldberg, Joanna B ^d   Sampaio, Elizabeth P ^a,e   Holland, Steven M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^e INSTITUTO OSWALDO CRUZ   (Brazil)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g MEDIMMUNE   (United States)

^h Hagerstown Community College   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BURKHOLDERIA; BURKHOLDERIA MULTIVORANS; CELL INTERACTION; CELL INVASION; CHRONIC GRANULOMATOUS DISEASE; CONTROLLED STUDY; DISEASE PREDISPOSITION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; LEUKOCYTE; MONOCYTE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SERRATIA MARCESCENS; SPLEEN;

ANIMALS; BACTERIAL ADHESION; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; CELLS, CULTURED; COLONY COUNT, MICROBIAL; CYTOKINES; ESCHERICHIA COLI; GRANULOMATOUS DISEASE, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; SERRATIA MARCESCENS; SPLEEN; VIRULENCE;

EID: 70349410331     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00259-09     Document Type: Article

References (46)

1. Baldwin, A., E. Mahenthiralingam, P. Drevinek, P. Vandamme, J. R. Govan, D. J. Waine, J. J. LiPuma, L. Chiarini, C. Dalmastri, D. A. Henry, D. P. Speert, D. Honeybourne, M. C. Maiden, and C. G. Dowson. 2007. Environmental Burkholderia cepacia complex isolates in human infections. Emerg. Infect. Dis. 13:458-461.
2. Bellinati-Pires, R., M. M. Salgado, I. P. Hypolito, A. S. Grumach, and M. M. Carneiro-Sampaio. 1995. Application of a fluorochrome-lysostaphin assay to the detection of phagocytic and bactericidal disturbances in human neutrophils and monocytes. J. Investig. Allergol. Clin. Immunol. 5:337-342.
3. Boyum, A. 1974. Separation of blood leucocytes, granulocytes and lymphocytes. Tissue Antigens 4:269-274.
4. Bressler, A. M., K. S. Kaye, J. J. LiPuma, A. D. Alexander, C. M. Moore, L. B. Reller, and C. W. Woods. 2007. Risk factors for Burkholderia cepacia complex bacteremia among intensive care unit patients without cystic fibrosis: a case control study. Infect. Control Hosp. Epidemiol. 28:951-958.
5. Burns, J. L., M. Jonas, E. Y. Chi, D. K. Clark, A. Berger, and A. Griffith. 1996. Invasion of respiratory epithelial cells by Burkholderia (Pseudomonas) cepacia. Infect. Immun. 64:4054-4059. (Pubitemid 26318122)
6. Bylund, J., P. A. Campsall, R. C. Ma, B. A. Conway, and D. P. Speert. 2005. Burkholderia cenocepacia induces neutrophil necrosis in chronic granulomatous disease. J. Immunol. 174:3562-3569.
7. Bylund, J., K. L. Macdonald, K. L. Brown, P. Mydel, L. V. Collins, R. E. Hancock, and D. P. Speert. 2007. Enhanced inflammatory responses of chronic granulomatous disease leukocytes involve ROS-independent activation of NF-kappa B. Eur. J. Immunol. 37:1087-1096.
8. Chiu, C. H., A. Ostry, and D. P. Speert. 2001. Invasion of murine respiratory epithelial cells in vivo by Burkholderia cepacia. J. Med. Microbiol. 50:594-601.
9. Chu, K. K., D. J. Davidson, T. K. Halsey, J. W. Chung, and D. P. Speert. 2002. Differential persistence among genomovars of the Burkholderia cepacia complex in a murine model of pulmonary infection. Infect. Immun. 70:2715-2720.
10. Cieri, M. V., N. Mayer-Hamblett, A. Griffith, and J. L. Burns. 2002. Correlation between an in vitro invasion assay and a murine model of Burkholderia cepacia lung infection. Infect. Immun. 70:1081-1086.
11. De Soyza, A., C. D. Ellis, C. M. Khan, P. A. Corris, and R. Demarco de Hormaeche. 2004. Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am. J. Respir. Crit. Care Med. 170:70-77.
12. Dinauer, M. C., M. A. Gifford, N. Pech, L. L. Li, and P. Emshwiller. 2001. Variable correction of host defense following gene transfer and bone marrow transplantation in murine X-linked chronic granulomatous disease. Blood 97:3738-3745.
13. Duff, C., P. G. Murphy, M. Callaghan, and S. McClean. 2006. Differences in invasion and translocation of Burkholderia cepacia complex species in polarised lung epithelial cells in vitro. Microb. Pathog. 41:183-192.
14. Fuchs, T. A., U. Abed, C. Goosmann, R. Hurwitz, I. Schulze, V. Wahn, Y. Weinrauch, V. Brinkmann, and A. Zychlinsky. 2007. Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176:231-241.
15. Govan, J. R., A. R. Brown, and A. M. Jones. 2007. Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection. Future Microbiol. 2:153-164.
16. Greenberg, D. E., J. B. Goldberg, F. Stock, P. R. Murray, S. M. Holland, and J. J. LiPuma. 2009. Recurrent Burkholderia infection in patients with chronic granulomatous disease: 11-year experience at a large referral center. Clin. Infect. Dis. 48:1577-1579.
17. Guide, S. V., F. Stock, V. J. Gill, V. L. Anderson, H. L. Malech, J. I. Gallin, and S. M. Holland. 2003. Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J. Infect. Dis. 187:845-853.
18. Hartl, D., N. Lehmann, F. Hoffmann, A. Jansson, A. Hector, G. Notheis, D. Roos, B. H. Belohradsky, and U. Wintergerst. 2008. Dysregulation of innate immune receptors on neutrophils in chronic granulomatous disease. J. Allergy Clin. Immunol. 121:375-382 e379.
19. Hasui, M., Y. Hirabayashi, K. Hattori, and Y. Kobayashi. 1991. Increased phagocytic activity of polymorphonuclear leukocytes of chronic granulomatous disease as determined with flow cytometric assay. J. Lab. Clin. Med. 117:291-298.
20. Jackson, S. H., J. I. Gallin, and S. M. Holland. 1995. The p47phox mouse knock-out model of chronic granulomatous disease. J. Exp. Med. 182:751-758.
21. Keig, P. M., E. Ingham, and K. G. Kerr. 2001. Invasion of human type II pneumocytes by Burkholderia cepacia. Microb. Pathog. 30:167-170.
22. Keig, P. M., E. Ingham, P. A. Vandamme, and K. G. Kerr. 2002. Differential invasion of respiratory epithelial cells by members of the Burkholderia cepacia complex. Clin. Microbiol. Infect. 8:47-49.
23. Kobayashi, S. D., J. M. Voyich, K. R. Braughton, A. R. Whitney, W. M. Nauseef, H. L. Malech, and F. R. DeLeo. 2004. Gene expression profiling provides insight into the pathophysiology of chronic granulomatous disease. J. Immunol. 172:636-643.
24. Lipuma, J. J. 2005. Update on the Burkholderia cepacia complex. Curr. Opin. Pulm. Med. 11:528-533.
25. Mahenthiralingam, E., T. A. Urban, and J. B. Goldberg. 2005. The multifarious, multireplicon Burkholderia cepacia complex. Nat. Rev. Microbiol. 3:144-156.
26. Mardiney, M., III, S. H. Jackson, S. K. Spratt, F. Li, S. M. Holland, and H. L. Malech. 1997. Enhanced host defense after gene transfer in the murine p47phox-deficient model of chronic granulomatous disease. Blood 89:2268-2275.
27. Mariathasan, S., and D. M. Monack. 2007. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat. Rev. Immunol. 7:31-40.
28. Martin, D. W., and C. D. Mohr. 2000. Invasion and intracellular survival of Burkholderia cepacia. Infect. Immun. 68:24-29.
29. Mohr, C. D., M. Tomich, and C. A. Herfst. 2001. Cellular aspects of Burkholderia cepacia infection. Microbes Infect. 3:425-435.
30. Moura, J. A., M. Cristina de Assis, G. C. Ventura, A. M. Saliba, L. Gonzaga, Jr., M. Si-Tahar, A. Marques Ede, and M. C. Plotkowski. 2008. Differential interaction of bacterial species from the Burkholderia cepacia complex with human airway epithelial cells. Microbes Infect. 10:52-59.
31. Pollock, J. D., D. A. Williams, M. A. Gifford, L. L. Li, X. Du, J. Fisherman, S. H. Orkin, C. M. Doerschuk, and M. C. Dinauer. 1995. Mouse model of X-linked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9:202-209.
32. Reik, R., T. Spilker, and J. J. Lipuma. 2005. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J. Clin. Microbiol. 43:2926-2928.
33. Saini, L. S., S. B. Galsworthy, M. A. John, and M. A. Valvano. 1999. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 145:3465-3475.
34. Sajjan, U., S. Keshavjee, and J. Forstner. 2004. Responses of well-differentiated airway epithelial cell cultures from healthy donors and patients with cystic fibrosis to Burkholderia cenocepacia infection. Infect. Immun. 72:4188-4199.
35. Sajjan, U., Y. Wu, G. Kent, and J. Forstner. 2000. Preferential adherence of cable-piliated Burkholderia cepacia to respiratory epithelia of CF knockout mice and human cystic fibrosis lung explants. J. Med. Microbiol. 49:875-885.
36. Schwab, U. E., C. M. Ribeiro, H. Neubauer, and R. C. Boucher. 2003. Role of actin filament network in Burkholderia multivorans invasion in well-differentiated human airway epithelia. Infect. Immun. 71:6607-6609.
37. Segal, B. H., L. Ding, and S. M. Holland. 2003. Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and Chromobacterium violaceum infection in mice. Infect. Immun. 71:205-210.
38. Segal, B. H., T. L. Leto, J. I. Gallin, H. L. Malech, and S. M. Holland. 2000. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore) 79:170-200. (Pubitemid 30327531)
39. phox-/- mice. Cell Microbiol. 9:2817-2825.
40. Speert, D. P., M. Bond, R. C. Woodman, and J. T. Curnutte. 1994. Infection with Pseudomonas cepacia in chronic granulomatous disease: role of nonoxidative killing by neutrophils in host defense. J. Infect. Dis. 170:1524-1531.
41. Stevens, J. M., R. L. Ulrich, L. A. Taylor, M. W. Wood, D. Deshazer, M. P. Stevens, and E. E. Galyov. 2005. Actin-binding proteins from Burkholderia mallei and Burkholderia thailandensis can functionally compensate for the actin-based motility defect of a Burkholderia pseudomallei bimA mutant. J. Bacteriol. 187:7857-7862.
42. Utaisincharoen, P., N. Anuntagool, S. Arjcharoen, I. Lengwehasatit, K. Limposuwan, P. Chaisuriya, and S. Sirisinha. 2004. Burkholderia pseudomallei stimulates low interleukin-8 production in the human lung epithelial cell line A549. Clin. Exp. Immunol. 138:61-65.
43. Valvano, M. A., K. E. Keith, and S. T. Cardona. 2005. Survival and persistence of opportunistic Burkholderia species in host cells. Curr. Opin. Microbiol. 8:99-105.
44. Winkelstein, J. A., M. C. Marino, R. B. Johnston, Jr., J. Boyle, J. Curnutte, J. I. Gallin, H. L. Malech, S. M. Holland, H. Ochs, P. Quie, R. H. Buckley, C. B. Foster, S. J. Chanock, and H. Dickler. 2000. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155-169.
45. Zahariadis, G., M. H. Levy, and J. L. Burns. 2003. Cepacia-like syndrome caused by Burkholderia multivorans. Can. J. Infect. Dis. 14:123-125.
46. Zughaier, S. M., H. C. Ryley, and S. K. Jackson. 1999. Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes. Infect. Immun. 67:1505-1507.